BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roche AM, King SJ, Weiser JN. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect Immun 2007;75:2469-75. [PMID: 17339359 DOI: 10.1128/IAI.01972-06] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Zangari T, Zafar MA, Lees JA, Abruzzo AR, Bee GCW, Weiser JN. Pneumococcal capsule blocks protection by immunization with conserved surface proteins. NPJ Vaccines 2021;6:155. [PMID: 34930916 DOI: 10.1038/s41541-021-00413-5] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
2 Kono M, Nanushaj D, Sakatani H, Murakami D, Hijiya M, Kinoshita T, Shiga T, Kaneko F, Enomoto K, Sugita G, Miyajima M, Okada Y, Saika S, Hotomi M. The Roles of Transient Receptor Potential Vanilloid 1 and 4 in Pneumococcal Nasal Colonization and Subsequent Development of Invasive Disease. Front Immunol 2021;12:732029. [PMID: 34804016 DOI: 10.3389/fimmu.2021.732029] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Ramos-Sevillano E, Ercoli G, Guerra-Assunção JA, Felgner P, Ramiro de Assis R, Nakajima R, Goldblatt D, Tetteh KKA, Heyderman RS, Gordon SB, Ferreria DM, Brown JS. Protective Effect of Nasal Colonisation with ∆cps/piaA and ∆cps/proABCStreptococcus pneumoniae Strains against Recolonisation and Invasive Infection. Vaccines (Basel) 2021;9:261. [PMID: 33804077 DOI: 10.3390/vaccines9030261] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Voß F, van Beek LF, Schwudke D, Ederveen THA, van Opzeeland FJ, Thalheim D, Werner S, de Jonge MI, Hammerschmidt S. Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection. Vaccines (Basel) 2020;8:E310. [PMID: 32560374 DOI: 10.3390/vaccines8020310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Amonov M, Simbak N, Wan Hassan WMR, Ismail S, A Rahman NI, Clarke SC, Yeo CC. Disruption of the cpsE and endA Genes Attenuates Streptococcus pneumoniae Virulence: Towards the Development of a Live Attenuated Vaccine Candidate. Vaccines (Basel) 2020;8:E187. [PMID: 32326482 DOI: 10.3390/vaccines8020187] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Jang AY, Ahn KB, Zhi Y, Ji HJ, Zhang J, Han SH, Guo H, Lim S, Song JY, Lim JH, Seo HS. Serotype-Independent Protection Against Invasive Pneumococcal Infections Conferred by Live Vaccine With lgt Deletion. Front Immunol 2019;10:1212. [PMID: 31191555 DOI: 10.3389/fimmu.2019.01212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 Shekhar S, Khan R, Schenck K, Petersen FC. Intranasal Immunization with the Commensal Streptococcus mitis Confers Protective Immunity against Pneumococcal Lung Infection. Appl Environ Microbiol 2019;85:e02235-18. [PMID: 30683742 DOI: 10.1128/AEM.02235-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
8 Ramos-Sevillano E, Ercoli G, Brown JS. Mechanisms of Naturally Acquired Immunity to Streptococcus pneumoniae. Front Immunol 2019;10:358. [PMID: 30881363 DOI: 10.3389/fimmu.2019.00358] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
9 Parveen N, Fernandez MC, Haynes AM, Zhang RL, Godornes BC, Centurion-Lara A, Giacani L. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates. Vaccine 2019;37:1807-18. [PMID: 30797635 DOI: 10.1016/j.vaccine.2019.02.022] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
10 Farhat K, Bodart G, Charlet-Renard C, Desmet CJ, Moutschen M, Beguin Y, Baron F, Melin P, Quatresooz P, Parent AS, Desmecht D, Sirard JC, Salvatori R, Martens H, Geenen VG. Growth Hormone (GH) Deficient Mice With GHRH Gene Ablation Are Severely Deficient in Vaccine and Immune Responses Against Streptococcus pneumoniae. Front Immunol 2018;9:2175. [PMID: 30333823 DOI: 10.3389/fimmu.2018.02175] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
11 Bou Ghanem EN, Maung NHT, Siwapornchai N, Goodwin AE, Clark S, Muñoz-Elías EJ, Camilli A, Gerstein RM, Leong JM. Nasopharyngeal Exposure to Streptococcus pneumoniae Induces Extended Age-Dependent Protection against Pulmonary Infection Mediated by Antibodies and CD138+ Cells. J Immunol 2018;200:3739-51. [PMID: 29661828 DOI: 10.4049/jimmunol.1701065] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
12 Zhang X, Cui J, Wu Y, Wang H, Wang J, Qiu Y, Mo Y, He Y, Zhang X, Yin Y, Xu W. Streptococcus pneumoniae Attenuated Strain SPY1 with an Artificial Mineral Shell Induces Humoral and Th17 Cellular Immunity and Protects Mice against Pneumococcal Infection. Front Immunol 2017;8:1983. [PMID: 29375585 DOI: 10.3389/fimmu.2017.01983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lee SO, Lee S, Kim SJ, Rhee DK. Korean Red Ginseng enhances pneumococcal Δpep27 vaccine efficacy by inhibiting reactive oxygen species production. J Ginseng Res 2019;43:218-25. [PMID: 30962736 DOI: 10.1016/j.jgr.2017.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
14 Qiu Y, Zhang X, Wang H, Zhang X, Mo Y, Sun X, Wang J, Yin Y, Xu W. Heterologous prime-boost immunization with live SPY1 and DnaJ protein of Streptococcus pneumoniae induces strong Th1 and Th17 cellular immune responses in mice. J Microbiol 2017;55:823-9. [PMID: 28956354 DOI: 10.1007/s12275-017-7262-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Kim GL, Seon SH, Rhee DK. Pneumonia and Streptococcus pneumoniae vaccine. Arch Pharm Res 2017;40:885-93. [PMID: 28735461 DOI: 10.1007/s12272-017-0933-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
16 Zangari T, Wang Y, Weiser JN. Streptococcus pneumoniae Transmission Is Blocked by Type-Specific Immunity in an Infant Mouse Model. mBio 2017;8:e00188-17. [PMID: 28292980 DOI: 10.1128/mBio.00188-17] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
17 Kirkham LS, Wiertsema SP, Corscadden KJ, Mateus T, Mullaney GL, Zhang G, Richmond PC, Thornton RB. Otitis-Prone Children Produce Functional Antibodies to Pneumolysin and Pneumococcal Polysaccharides. Clin Vaccine Immunol 2017;24:e00497-16. [PMID: 28031178 DOI: 10.1128/CVI.00497-16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
18 Wilson R, Cohen JM, Reglinski M, Jose RJ, Chan WY, Marshall H, de Vogel C, Gordon S, Goldblatt D, Petersen FC, Baxendale H, Brown JS. Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens. PLoS Pathog 2017;13:e1006137. [PMID: 28135322 DOI: 10.1371/journal.ppat.1006137] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 10.2] [Reference Citation Analysis]
19 Kono M, Zafar MA, Zuniga M, Roche AM, Hamaguchi S, Weiser JN. Single Cell Bottlenecks in the Pathogenesis of Streptococcus pneumoniae. PLoS Pathog 2016;12:e1005887. [PMID: 27732665 DOI: 10.1371/journal.ppat.1005887] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
20 Mitsi E, Roche AM, Reiné J, Zangari T, Owugha JT, Pennington SH, Gritzfeld JF, Wright AD, Collins AM, van Selm S, de Jonge MI, Gordon SB, Weiser JN, Ferreira DM. Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage. Mucosal Immunol 2017;10:385-94. [PMID: 27579859 DOI: 10.1038/mi.2016.71] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
21 Zafar MA, Kono M, Wang Y, Zangari T, Weiser JN. Infant Mouse Model for the Study of Shedding and Transmission during Streptococcus pneumoniae Monoinfection. Infect Immun 2016;84:2714-22. [PMID: 27400721 DOI: 10.1128/IAI.00416-16] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
22 Nakamura S, Iwanaga N, Seki M, Fukudome K, Oshima K, Miyazaki T, Izumikawa K, Yanagihara K, Miyazaki Y, Mukae H, Kohno S. Toll-Like Receptor 4 Agonistic Antibody Promotes Host Defense against Chronic Pseudomonas aeruginosa Lung Infection in Mice. Infect Immun 2016;84:1986-93. [PMID: 27091927 DOI: 10.1128/IAI.01384-15] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
23 Rosch JW. Promises and pitfalls of live attenuated pneumococcal vaccines. Hum Vaccin Immunother 2014;10:3000-3. [PMID: 25483458 DOI: 10.4161/21645515.2014.970496] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
24 Blevins LK, Wren JT, Holbrook BC, Hayward SL, Swords WE, Parks GD, Alexander-Miller MA. Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response. J Immunol 2014;193:5076-87. [PMID: 25311807 DOI: 10.4049/jimmunol.1400529] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
25 Xu X, Wang H, Liu Y, Wang Y, Zeng L, Wu K, Wang J, Ma F, Xu W, Yin Y, Zhang X. Mucosal immunization with the live attenuated vaccine SPY1 induces humoral and Th2-Th17-regulatory T cell cellular immunity and protects against pneumococcal infection. Infect Immun 2015;83:90-100. [PMID: 25312946 DOI: 10.1128/IAI.02334-14] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
26 Rosch JW, Iverson AR, Humann J, Mann B, Gao G, Vogel P, Mina M, Murrah KA, Perez AC, Edward Swords W, Tuomanen EI, McCullers JA. A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media. EMBO Mol Med 2014;6:141-54. [PMID: 24408968 DOI: 10.1002/emmm.201202150] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
27 Roche AM, Richard AL, Rahkola JT, Janoff EN, Weiser JN. Antibody blocks acquisition of bacterial colonization through agglutination. Mucosal Immunol 2015;8:176-85. [PMID: 24962092 DOI: 10.1038/mi.2014.55] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
28 Das R, LaRose MI, Hergott CB, Leng L, Bucala R, Weiser JN. Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization. J Immunol 2014;193:764-72. [PMID: 24928996 DOI: 10.4049/jimmunol.1400133] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
29 Xu X, Meng J, Wang Y, Zheng J, Wu K, Zhang X, Yin Y, Zhang Q. Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1. J Microbiol 2014;52:315-23. [PMID: 24682994 DOI: 10.1007/s12275-014-3583-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
30 Runco LM, Stauft CB, Coleman JR. Tailoring the Immune Response via Customization of Pathogen Gene Expression. J Pathog 2014;2014:651568. [PMID: 24719769 DOI: 10.1155/2014/651568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
31 Puchta A, Verschoor CP, Thurn T, Bowdish DM. Characterization of inflammatory responses during intranasal colonization with Streptococcus pneumoniae. J Vis Exp 2014;:e50490. [PMID: 24472828 DOI: 10.3791/50490] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
32 Xu Q, Pichichero ME. Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children. Vaccine 2014;32:706-11. [PMID: 24355091 DOI: 10.1016/j.vaccine.2013.11.096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
33 Ferreira DM, Neill DR, Bangert M, Gritzfeld JF, Green N, Wright AK, Pennington SH, Bricio-Moreno L, Moreno AT, Miyaji EN, Wright AD, Collins AM, Goldblatt D, Kadioglu A, Gordon SB. Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med 2013;187:855-64. [PMID: 23370916 DOI: 10.1164/rccm.201212-2277OC] [Cited by in Crossref: 111] [Cited by in F6Publishing: 105] [Article Influence: 12.3] [Reference Citation Analysis]
34 Muchnik L, Adawi A, Ohayon A, Dotan S, Malka I, Azriel S, Shagan M, Portnoi M, Kafka D, Nahmani H, Porgador A, Gershoni JM, Morrison DA, Mitchell A, Tal M, Ellis R, Dagan R, Nebenzahl YM. NADH oxidase functions as an adhesin in Streptococcus pneumoniae and elicits a protective immune response in mice. PLoS One 2013;8:e61128. [PMID: 23577197 DOI: 10.1371/journal.pone.0061128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
35 Choi SY, Tran TD, Briles DE, Rhee DK. Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice. Clin Exp Vaccine Res 2013;2:58-65. [PMID: 23596592 DOI: 10.7774/cevr.2013.2.1.58] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
36 Mukerji R, Mirza S, Roche AM, Widener RW, Croney CM, Rhee DK, Weiser JN, Szalai AJ, Briles DE. Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine. J Immunol 2012;189:5327-35. [PMID: 23105137 DOI: 10.4049/jimmunol.1201967] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 6.2] [Reference Citation Analysis]
37 Banham-Hall E, Clatworthy MR, Okkenhaug K. The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases. Open Rheumatol J 2012;6:245-58. [PMID: 23028409 DOI: 10.2174/1874312901206010245] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 6.8] [Reference Citation Analysis]
38 Lijek RS, Luque SL, Liu Q, Parker D, Bae T, Weiser JN. Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenase. Proc Natl Acad Sci U S A 2012;109:13823-8. [PMID: 22869727 DOI: 10.1073/pnas.1208075109] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
39 Cohen JM, Chimalapati S, de Vogel C, van Belkum A, Baxendale HE, Brown JS. Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation. Vaccine 2012;30:4453-9. [PMID: 22561489 DOI: 10.1016/j.vaccine.2012.04.080] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
40 Chimalapati S, Cohen J, Brown JS, Camilli A. Reply to “Cross-Protective Immunity against Heterologous Streptococcus pneumoniae”. Infect Immun 2012;80:1946-1946. [DOI: 10.1128/iai.00098-12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Wright AK, Ferreira DM, Gritzfeld JF, Wright AD, Armitage K, Jambo KC, Bate E, El Batrawy S, Collins A, Gordon SB. Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage. PLoS Pathog 2012;8:e1002622. [PMID: 22496648 DOI: 10.1371/journal.ppat.1002622] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
42 Moreno AT, Oliveira ML, Ho PL, Vadesilho CF, Palma GM, Ferreira JM Jr, Ferreira DM, Santos SR, Martinez MB, Miyaji EN. Cross-reactivity of antipneumococcal surface protein C (PspC) antibodies with different strains and evaluation of inhibition of human complement factor H and secretory IgA binding via PspC. Clin Vaccine Immunol 2012;19:499-507. [PMID: 22336290 DOI: 10.1128/CVI.05706-11] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
43 Cohen JM, Khandavilli S, Camberlein E, Hyams C, Baxendale HE, Brown JS. Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation. PLoS One 2011;6:e25558. [PMID: 22003400 DOI: 10.1371/journal.pone.0025558] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]
44 Chimalapati S, Cohen J, Camberlein E, Durmort C, Baxendale H, de Vogel C, van Belkum A, Brown JS. Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains. Infect Immun 2011;79:4965-76. [PMID: 21947774 DOI: 10.1128/IAI.05923-11] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
45 Coleman JR, Papamichail D, Yano M, García-Suárez Mdel M, Pirofski LA. Designed reduction of Streptococcus pneumoniae pathogenicity via synthetic changes in virulence factor codon-pair bias. J Infect Dis 2011;203:1264-73. [PMID: 21343143 DOI: 10.1093/infdis/jir010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
46 Roche AM, Weiser JN. Identification of the targets of cross-reactive antibodies induced by Streptococcus pneumoniae colonization. Infect Immun 2010;78:2231-9. [PMID: 20231407 DOI: 10.1128/IAI.01058-09] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
47 Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. 2010;16:228-231. [PMID: 20081863 DOI: 10.1038/nm.2087] [Cited by in Crossref: 699] [Cited by in F6Publishing: 714] [Article Influence: 58.3] [Reference Citation Analysis]
48 Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun 2010;78:704-15. [PMID: 19948837 DOI: 10.1128/IAI.00881-09] [Cited by in Crossref: 237] [Cited by in F6Publishing: 233] [Article Influence: 18.2] [Reference Citation Analysis]
49 Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest. 2009;119:1899-1909. [PMID: 19509469 DOI: 10.1172/jci36731] [Cited by in Crossref: 95] [Cited by in F6Publishing: 253] [Article Influence: 7.3] [Reference Citation Analysis]
50 Ferreira DM, Darrieux M, Silva DA, Leite LC, Ferreira JM Jr, Ho PL, Miyaji EN, Oliveira ML. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin Vaccine Immunol 2009;16:636-45. [PMID: 19279169 DOI: 10.1128/CVI.00395-08] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 6.3] [Reference Citation Analysis]
51 Trune DR, Zheng QY. Mouse models for human otitis media. Brain Res 2009;1277:90-103. [PMID: 19272362 DOI: 10.1016/j.brainres.2009.02.047] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
52 Beisswenger C, Lysenko ES, Weiser JN. Early bacterial colonization induces toll-like receptor-dependent transforming growth factor beta signaling in the epithelium. Infect Immun 2009;77:2212-20. [PMID: 19255194 DOI: 10.1128/IAI.01224-08] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
53 Chiavolini D, Pozzi G, Ricci S. Animal models of Streptococcus pneumoniae disease. Clin Microbiol Rev 2008;21:666-85. [PMID: 18854486 DOI: 10.1128/CMR.00012-08] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 5.6] [Reference Citation Analysis]
54 Trzciński K, Thompson CM, Srivastava A, Basset A, Malley R, Lipsitch M. Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect Immun 2008;76:2678-84. [PMID: 18391006 DOI: 10.1128/IAI.00141-08] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 4.7] [Reference Citation Analysis]
55 Sabirov A, Metzger DW. Mouse models for the study of mucosal vaccination against otitis media. Vaccine 2008;26:1501-24. [PMID: 18295938 DOI: 10.1016/j.vaccine.2008.01.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
56 Burnaugh AM, Frantz LJ, King SJ. Growth of Streptococcus pneumoniae on human glycoconjugates is dependent upon the sequential activity of bacterial exoglycosidases. J Bacteriol 2008;190:221-30. [PMID: 17981977 DOI: 10.1128/JB.01251-07] [Cited by in Crossref: 123] [Cited by in F6Publishing: 115] [Article Influence: 8.2] [Reference Citation Analysis]